Chemotherapy- and Irradiation-Induced Bone Loss in Adults with Solid Tumors

Por Wissing, Michel D.
Publicado no Curr Osteoporos Rep (2015)

The use of perioperative chemotherapy in patients undergoing radical cystectomy for bladder cancer in Quebec, Canada, 2000–2016

Por Wissing, Michel D., Kassouf, Wassim, Tanguay, Simon, Aprikian, Armen G.
Publicado no Can Urol Assoc J (2020)

Vaccination of young women decreases human papillomavirus transmission in heterosexual couples: findings from the HITCH cohort study

Por Wissing, Michel D., Burchell, Ann N., El-Zein, Mariam, Tellier, Pierre-Paul, Coutlée, François, Franco, Eduardo L.
Publicado no Cancer Epidemiol Biomarkers Prev (2019)

Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression

Por WISSING, MICHEL D., DADON, TIKVA, KIM, EUNICE, PIONTEK, KLAUS B., SHIM, JOONG S., KAELBER, NADINE S., LIU, JUN O., KACHHAP, SUSHANT K., NELKIN, BARRY D.
Publicado em 2014

Human Papillomavirus Viral Load and Transmission in Young, Recently Formed Heterosexual Couples

Por Wissing, Michel D, Louvanto, Karolina, Comète, Emilie, Burchell, Ann N, El-Zein, Mariam, Rodrigues, Allita, Tellier, Pierre-Paul, Coutlée, François, Franco, Eduardo L
Publicado no J Infect Dis (2019)

Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors

Por Wissing, Michel D., Mendonca, Janet, Kortenhorst, Madeleine S. Q., Kaelber, Nadine S., Gonzalez, Matthew, Kim, Eunice, Hammers, Hans, van Diest, Paul J., Carducci, Michael A., Kachhap, Sushant K.
Publicado em 2013

Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells

Por Wissing, Michel D., Mendonca, Janet, Kim, Eunice, Kim, Eugene, Shim, Joong S., Kaelber, Nadine S., Kant, Huub, Hammers, Hans, Commes, Therese, Van Diest, Paul J., Liu, Jun O., Kachhap, Sushant K.
Publicado em 2013

Nuclear Eg5 (kinesin spindle protein) expression predicts docetaxel response and prostate cancer aggressiveness

Por Wissing, Michel D., De Morrée, Ellen S., Dezentjé, Vincent O., Buijs, Jeroen T., De Krijger, Ronald R., Smit, Vincent T.H.B.M., Van Weerden, Wytske M., Gelderblom, Hans, van der Pluijm, Gabri
Publicado em 2014

Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors

Por Kortenhorst, Madeleine SQ, Wissing, Michel D, Rodriguez, Ronald, Kachhap, Sushant K, Jans, Judith JM, Van der Groep, Petra, Verheul, Henk MW, Gupta, Anuj, Aiyetan, Paul O, van der Wall, Elsken, Carducci, Michael A, Van Diest, Paul J, Marchionni, Luigi
Publicado em 2013

Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor

Por Kachhap, Sushant K., Rosmus, Nadine, Collis, Spencer J., Kortenhorst, Madeleine S. Q., Wissing, Michel D., Hedayati, Mohammad, Shabbeer, Shabana, Mendonca, Janet, Deangelis, Justin, Marchionni, Luigi, Lin, Jianqing, Höti, Naseruddin, Nortier, Johan W. R., DeWeese, Theodore L., Hammers, Hans, Carducci, Michael A.
Publicado em 2010

Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer

Por Paller, Channing J, Wissing, Michel D, Mendonca, Janet, Sharma, Anup, Kim, Eugene, Kim, Hea-Soo, Kortenhorst, Madeleine S Q, Gerber, Stephanie, Rosen, Marc, Shaikh, Faraz, Zahurak, Marianna L, Rudek, Michelle A, Hammers, Hans, Rudin, Charles M, Carducci, Michael A, Kachhap, Sushant K
Publicado no Cancer Med (2014)